ArticleFrontiers in pediatrics2026
Management of multiple drug hypersensitivity in a child with very severe aplastic anemia: a case report and therapeutic challenge.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work presents the case of a pediatric patient with very severe aplastic anemia (VSAA) who developed severe hypersensitivity reactions sequentially to a carbapenem antibiotic and subsequently to intravenous levofloxacin during an episode of severe neutropenia with fever. This case illustrates that serious drug hypersensitivity reactions can occur even in the context of profound immunosuppression. In managing this complex scenario, the Naranjo Algorithm was utilized to identify the culprit medications. When adjusting the anti-infective regimen, we carefully balanced the benefits and risks, ultimately selecting appropriate alternative antimicrobial agents. Furthermore, the patient tolerated a switch from intravenous to oral levofloxacin without further adverse reactions, leading to a successful discharge. This case highlights the need for heightened vigilance among clinicians and pharmacists regarding the potential for severe drug allergies in immunocompromised, critically ill patients. This case also aims to share practical experience, hoping to provide a reference for the challenging decision-making process of anti-infective therapy in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.